These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Urinary 5-HIAA stimulation test for the diagnosis of carcinoid syndrome caused by carcinoid tumors of the middle intestine]. Varas MJ; Navarro MA; Rosell P; García F Rev Esp Enferm Apar Dig; 1986 Oct; 70(4):311-5. PubMed ID: 2431444 [No Abstract] [Full Text] [Related]
4. Normal 5-hydroxyindole excretion in the presence of carcinoid syndrome. Wiles P; Hampton K; Dean H; Feely M Ir Med J; 1987 Apr; 80(4):122-3. PubMed ID: 2439475 [No Abstract] [Full Text] [Related]
5. Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion. Gillett DJ; Smith RC Am J Surg; 1974 Jul; 128(1):95-9. PubMed ID: 4276000 [No Abstract] [Full Text] [Related]
6. The functioning carcinoid tumor: a serendipity in diagnosis. Mattingly TW; Andrus EC; Biörck G; Manion WC Trans Am Clin Climatol Assoc; 1966; 77():190-204. PubMed ID: 5885902 [No Abstract] [Full Text] [Related]
7. [Laboratory findings in the carcinoid syndrome]. Kähler HJ Dtsch Med Wochenschr; 1968 May; 93(19):959-61. PubMed ID: 5300909 [No Abstract] [Full Text] [Related]
8. N-acetyl-L-cysteine: an alternative to 2-mercaptoethanol in the reduction of Udenfriend's chromophore used for the determination of urinary 5-hydroxyindoleacetic acid. Zouheir Habbal M Clin Chim Acta; 1983 May; 130(2):251-6. PubMed ID: 6191888 [No Abstract] [Full Text] [Related]
9. [The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine]. Simon J; Láhn V; Opatrný K; Sova J; Sídlová A; Cerhová M; Hůla J; Virt S Cas Lek Cesk; 1968 Mar; 107(13):394-8. PubMed ID: 5664817 [No Abstract] [Full Text] [Related]
11. The incidence of elevations in urine 5-hydroxyindoleacetic acid. Nuttall KL; Pingree SS Ann Clin Lab Sci; 1998; 28(3):167-74. PubMed ID: 9646859 [TBL] [Abstract][Full Text] [Related]
12. [Carcinoid tumor of the small intestine complicated by endocardial fibrosis of the right heart]. Grand A; Bourret M; Loire R; Chapuy A Arch Mal Coeur Vaiss; 1971 Jan; 64(1):85-101. PubMed ID: 4995514 [No Abstract] [Full Text] [Related]
13. [Treatment of carcinoid syndrome with ocreotide (SMS-201-995)]. Rodríguez-García JL; Arechaga S; Fraile G; Serrano M Rev Clin Esp; 1992 Jul; 191(3):168. PubMed ID: 1380173 [No Abstract] [Full Text] [Related]
14. High-performance liquid chromatographic determination of 5-hydroxyindole-3-acetic acid in urine using Sephadex G-10 for isolation. Fornstedt N J Chromatogr; 1980 Mar; 181(3-4):456-62. PubMed ID: 6156180 [No Abstract] [Full Text] [Related]
15. Colorimetric assay of urinary 5-hydroxy-3-indoleacetic acid. Shihabi ZK; Wilson EL Clin Biochem; 1982 Apr; 15(2):106-8. PubMed ID: 6178531 [TBL] [Abstract][Full Text] [Related]
16. Catecholamine metabolism in the carcinoid syndrome. Feldman JM; Butler SS; Chapman BA; Bivens CE Clin Chim Acta; 1974 Feb; 51(1):75-81. PubMed ID: 4822816 [No Abstract] [Full Text] [Related]
17. [Excretion of 5-hydroxyindoleacetic acid in carcinoid syndrome]. Opatrný K; Láhn V; Sova J; Simon J; Virt S; Schwartz A; Levý J Z Gesamte Inn Med; 1968 Sep; 23(18):553-6. PubMed ID: 5710484 [No Abstract] [Full Text] [Related]